NCT05446493View on ClinicalTrials.gov

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 15, 2021

Study Completion Date

January 5, 2022

Conditions
Erectile DysfunctionErectile Dysfunction With Diabetes Mellitus
Interventions
DRUG

Tadalafil 5mg

"* Estimate serum level of serum YKL-40, total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3months.~* Penile color Doppler ultrasound examination before and after treatment"

Trial Locations (1)

81528

Aswan university, Aswān

All Listed Sponsors
lead

Aswan University

OTHER

NCT05446493 - Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction | Biotech Hunter | Biotech Hunter